-
Genflow Biosciences Reports Strong Safety Profile After Completing Dosing of AAV SIRT6 Gene Therapy in Canine Clinical Trial
Dec 16 2025 -
AAV Gene Therapy Using AAV-Ant1 Successfully Restores Mitochondrial Function to Halt Dilated Cardiomyopathy in Mouse Models
Dec 16 2025 -
Kyverna’s CAR-T Therapy Succeeds in Stiff Person Syndrome Trial and Targets First Autoimmune Approval
Dec 15 2025 -
Link Cell Therapies Launches with $60M Series A to Advance Logic-Gated CAR-T for Solid Tumors
Dec 15 2025 -
CIRM Awarded $7.4 Million Grant to Advance Novel AAV Gene Therapy for Rare Muscular Dystrophy
Dec 15 2025 -
Tenaya’s AAV Gene Therapy TN-401 Shows Early Safety and Arrhythmia Reduction in ARVC Patients
Dec 11 2025 -
Tetraneuron Secures Funding to Advance First-in-Class AAV Gene Therapy for Alzheimer’s disease
Dec 11 2025 -
FDA Approves First LVV-based Gene Therapy for Wiskott-Aldrich Syndrome
Dec 10 2025 -
Diakonos Oncology Secures $7M CPRIT Grant to Advance Personalized Dendritic Cell Vaccine for Refractory Melanoma
Dec 10 2025